The latest report by IMARC Group, titled “Bromelain Market Report by Source (Stem, Fruit), Application (Healthcare, Food and Beverages, Cosmetics, and Others), and Region 2024-2032“, The global bromelain market size is expected to exhibit a growth rate (CAGR) of 6.3% during 2024-2032.
Bromelain is a proteolytic enzyme derived from the fruit, stem, and juice of the pineapple plant. It plays a significant role in preventing the aggregation of blood platelets, thereby lowering the risk of arterial thrombosis and embolism, making it a common choice for the treatment of cardiovascular diseases (CVDs). This enzyme also possesses compounds that disrupt tumor cell activity and slow down the clotting process. Furthermore, it stimulates the production of substances that combat swelling and pain, and it acts as a fibrinolytic agent by facilitating the conversion of plasminogen to plasmin, which aids in fibrinolysis. Additionally, when applied as a topical cream, bromelain is highly effective in safely removing damaged tissue from wounds and treating second and third-degree burns. It is frequently utilized as an alternative to nonsteroidal anti-inflammatory drugs (NSAIDs) in homeopathic practices. Moreover, bromelain helps reduce swelling, congestion, and joint stiffness, and it is beneficial in managing inflammatory bowel disorders. Due to these numerous advantages, bromelain is extensively utilized in the healthcare, cosmetics, and food and beverage (F&B) industries worldwide.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/bromelain-market/requestsample
Bromelain Market Trends and Drivers:
The market is significantly influenced by the growth of the healthcare sector. Additionally, the increasing prevalence of conditions such as cancer, asthma, rheumatoid arthritis, and cardiovascular diseases (CVDs) is further propelling market expansion. Correspondingly, the heightened demand for bromelain within the pharmaceutical industry, attributed to its anti-inflammatory and analgesic effects, is also impacting market dynamics. Bromelain is frequently utilized as a dietary supplement to mitigate post-surgical discomfort and bruising. It is effective in alleviating symptoms related to osteoarthritis, diarrhea, and diabetes, while also improving the absorption of medications, including antibiotics. Furthermore, the extensive use of bromelain by athletes to manage acute inflammation from injuries serves as another significant factor driving market growth. It is also employed in the treatment of chronic inflammatory, malignant, and autoimmune disorders. In addition, the increasing requirement for bromelain to maintain its efficacy when absorbed in the intestines is advancing its application as an oral enzyme therapy for oncology patients. The rising demand for bromelain in the food and beverage (F&B) sector, particularly in the meat and seafood categories for tenderizing purposes, is further enhancing market growth. Moreover, the bromelain market is experiencing varied growth rates across different regions, with North America emerging as one of the largest markets due to the escalating demand in healthcare, rising disposable incomes, and growing awareness of bromelain's benefits. Additionally, the industry is anticipated to encounter heightened competition in the coming years, as key players adopt competitive strategies to maintain their market presence. For example, in 2017, Advanced Enzymes Technologies Limited acquired a 100% stake in evoxx technologies GmbH, a company based in Germany. This strategic acquisition has enabled Advanced Enzymes to bolster its research and development (R&D) capabilities.
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Source:
- Stem
- Fruit
Breakup by Application:
- Healthcare
- Food and Beverages
- Cosmetics
- Others
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- Advanced Enzyme Technologies Limited
- Bio-gen Extracts Private Limited.
- Changsha Natureway Co. Ltd.
- Creative Enzymes
- Enzybel International (Floridienne S.A.)
- Enzyme Development Corporation
- Enzyme Technologies (PTY) Ltd.
- Guangxi Nanning Javely Biological Products Co. Ltd.
- Hong Mao Biochemicals Co. Ltd.
- Mitushi Biopharma
- Xena Bio Herbals Pvt. Ltd.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
